DZ Bank AG reaffirmed their buy rating on shares of Fresenius Medical Care AG (NYSE:FMS) in a report released on Thursday.

Several other analysts have also issued reports on the stock. RBC Capital Markets restated a sector perform rating and issued a $44.00 price target (up from $41.00) on shares of Fresenius Medical Care AG in a research report on Tuesday, November 1st. Royal Bank Of Canada raised their price target on shares of Fresenius Medical Care AG from $41.00 to $44.00 and gave the stock a sector perform rating in a research report on Tuesday, November 1st. HSBC reiterated a hold rating on shares of Fresenius Medical Care AG in a research report on Tuesday, October 18th. Citigroup Inc. reiterated a buy rating on shares of Fresenius Medical Care AG in a research report on Tuesday, October 18th. Finally, SunTrust Banks Inc. set a $48.00 target price on shares of Fresenius Medical Care AG and gave the company a buy rating in a research report on Thursday, October 13th. Six equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. The stock presently has a consensus rating of Buy and an average price target of $45.33.

Fresenius Medical Care AG (NYSE:FMS) traded down 1.10% during midday trading on Thursday, reaching $38.74. 36,246 shares of the company traded hands. Fresenius Medical Care AG has a 12 month low of $38.26 and a 12 month high of $47.52. The firm’s 50 day moving average price is $41.24 and its 200 day moving average price is $43.17. The firm has a market capitalization of $23.72 billion, a price-to-earnings ratio of 20.24 and a beta of 0.58.

Fresenius Medical Care AG (NYSE:FMS) last posted its quarterly earnings results on Thursday, October 27th. The company reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.57. The company had revenue of $4.60 billion for the quarter, compared to analyst estimates of $4.55 billion. Fresenius Medical Care AG had a net margin of 6.67% and a return on equity of 10.56%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period last year, the business posted $0.93 EPS. On average, analysts expect that Fresenius Medical Care AG will post $2.02 earnings per share for the current year.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in FMS. Harding Loevner LP boosted its position in shares of Fresenius Medical Care AG by 40.8% in the third quarter. Harding Loevner LP now owns 3,332,640 shares of the company’s stock valued at $145,870,000 after buying an additional 966,390 shares during the last quarter. Ferguson Wellman Capital Management Inc. acquired a new position in shares of Fresenius Medical Care AG during the second quarter valued at approximately $5,796,000. Cambiar Investors LLC boosted its position in shares of Fresenius Medical Care AG by 5.2% in the second quarter. Cambiar Investors LLC now owns 2,333,733 shares of the company’s stock valued at $101,681,000 after buying an additional 114,840 shares during the last quarter. Royal Bank of Canada boosted its position in shares of Fresenius Medical Care AG by 23.2% in the first quarter. Royal Bank of Canada now owns 529,505 shares of the company’s stock valued at $23,340,000 after buying an additional 99,742 shares during the last quarter. Finally, Northern Trust Corp boosted its position in shares of Fresenius Medical Care AG by 12.2% in the third quarter. Northern Trust Corp now owns 761,955 shares of the company’s stock valued at $33,351,000 after buying an additional 83,125 shares during the last quarter. Institutional investors own 2.49% of the company’s stock.

Fresenius Medical Care AG Company Profile

Fresenius Medical Care AG & Co KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end stage renal disease (ESRD), as well as other healthcare services. The Company operates through four segments: North America, Europe, Middle East, Africa (EMEA), Asia-Pacific and Latin America.

5 Day Chart for NYSE:FMS

Receive News & Stock Ratings for Fresenius Medical Care AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG and related stocks with our FREE daily email newsletter.